Oligomeric and fibrillar species of β-amyloid (Aβ42) both impair mitochondrial function in P301L tau transgenic mice
Open Access
- 16 August 2008
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 86 (11) , 1255-1267
Abstract
We recently provided evidence for a mitochondrial dysfunction in P301L tau transgenic mice, a strain modeling the tau pathology of Alzheimer’s disease (AD) and frontotemporal dementia (FTD). In addition to tau aggregates, the AD brain is further characterized by Aβ peptide-containing plaques. When we addressed the role of Aβ, this indicated a synergistic action of tau and Aβ pathology on the mitochondria. In the present study, we compared the toxicity of different Aβ42 conformations in light of recent studies suggesting that oligomeric rather than fibrillar Aβ might be the actual toxic species. Interestingly, both oligomeric and fibrillar, but not disaggregated (mainly monomeric) Aβ42 caused a decreased mitochondrial membrane potential in cortical brain cells obtained from FTD P301L tau transgenic mice. This was not observed with cerebellar preparations indicating selective vulnerability of cortical neurons. Furthermore, we found reductions in state 3 respiration, the respiratory control ratio, and uncoupled respiration when incubating P301L tau mitochondria either with oligomeric or fibrillar preparations of Aβ42. Finally, we found that aging specifically increased the sensitivity of mitochondria to oligomeric Aβ42 damage indicating that oligomeric and fibrillar Aβ42 are both toxic, but exert different degrees of toxicity.Keywords
This publication has 56 references indexed in Scilit:
- Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's diseaseTrends in Molecular Medicine, 2008
- Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Aβ protofibrilsProceedings of the National Academy of Sciences, 2007
- Mitochondrial dysfunction and oxidative stress in neurodegenerative diseasesNature, 2006
- Tau phosphorylation and aggregation in Alzheimer's disease pathologyFEBS Letters, 2006
- Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's diseaseThe FASEB Journal, 2005
- The role of cell-derived oligomers of Aβ in Alzheimer's disease and avenues for therapeutic interventionBiochemical Society Transactions, 2005
- Accelerated extinction of conditioned taste aversion in P301L tau transgenic miceNeurobiology of Disease, 2004
- Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolutionJournal of Molecular Medicine, 2003
- Amyloid β peptides act directly on single neuronsNeuroscience Letters, 1993
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991